Literature DB >> 19614619

miR-21 as a key regulator of oncogenic processes.

S Duygu Selcuklu1, Mark T A Donoghue, Charles Spillane.   

Abstract

Small non-coding miRNAs (microRNAs) are emerging as key factors involved in cancer at all stages ranging from initiation to metastasis. MIRN21 is an miRNA gene that codes for the miR-21 miRNA which has been found to be overexpressed in many tumour samples where it has been analysed. Whereas consistent overexpression of miR-21 in tumours could be suggestive of functional effects of miR-21 in cancer, more in-depth functional studies with miR-21 are demonstrating that mir-21 displays oncogenic activity and can be classed as an oncomir. Extensive efforts are underway to identify the downstream genes and gene networks regulated by miR-21 and to identify the upstream factors that are regulating expression of miR-21. Even though miR-21 is one of the most intensively studied miRNAs, for all miRNAs, our understanding of miRNA signalling pathways is currently in its early stages. The unravelling of such RNA signalling pathways and networks will be key to understanding the role that dysregulated miRNA functioning can play in oncogenic processes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19614619     DOI: 10.1042/BST0370918

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  189 in total

1.  Transcriptional regulation of the protocadherin β cluster during Her-2 protein-induced mammary tumorigenesis results from altered N-glycan branching.

Authors:  Huabei Guo; Alison Nairn; Mitche dela Rosa; Tamas Nagy; Shaying Zhao; Kelley Moremen; Michael Pierce
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

2.  Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo.

Authors:  Arti B Gaur; Susan L Holbeck; Nancy H Colburn; Mark A Israel
Journal:  Neuro Oncol       Date:  2011-06       Impact factor: 12.300

Review 3.  Shielding the messenger (RNA): microRNA-based anticancer therapies.

Authors:  Elena Sotillo; Andrei Thomas-Tikhonenko
Journal:  Pharmacol Ther       Date:  2011-04-14       Impact factor: 12.310

Review 4.  The role of microRNAs in colorectal cancer.

Authors:  Aaron J Schetter; Hirokazu Okayama; Curtis C Harris
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

Review 5.  MicroRNAs: redefining mechanisms in cardiac disease.

Authors:  Gerald W Dorn
Journal:  J Cardiovasc Pharmacol       Date:  2010-12       Impact factor: 3.105

6.  MicroRNAs in Cerebral Ischemia.

Authors:  Kai-Ying Lim; Jia-Hui Chua; Jun-Rong Tan; Priyadharshni Swaminathan; Sugunavathi Sepramaniam; Arunmozhiarasi Armugam; Peter Tsun-Hon Wong; Kandiah Jeyaseelan
Journal:  Transl Stroke Res       Date:  2010-12       Impact factor: 6.829

7.  Emerging role of microRNA-21 in cancer.

Authors:  Yin-Hsun Feng; Chao-Jung Tsao
Journal:  Biomed Rep       Date:  2016-08-26

8.  Serum microRNA-21 expression as a prognostic and therapeutic biomarker for breast cancer patients.

Authors:  Prasant Yadav; Masroor Mirza; Kajal Nandi; S K Jain; R C M Kaza; Nita Khurana; P C Ray; Alpana Saxena
Journal:  Tumour Biol       Date:  2016-09-30

9.  Altering β-cell number through stable alteration of miR-21 and miR-34a expression.

Authors:  Marie Balslev Backe; Guy Wayne Novotny; Dan Ploug Christensen; Lars Groth Grunnet; Thomas Mandrup-Poulsen
Journal:  Islets       Date:  2014       Impact factor: 2.694

10.  MicroRNA expression in head and neck cancer associates with alcohol consumption and survival.

Authors:  Michele Avissar; Michael D McClean; Karl T Kelsey; Carmen J Marsit
Journal:  Carcinogenesis       Date:  2009-12       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.